What to expect for cannabis in 2022
The year ahead looks bright for cannabis, with all signs pointing to sustained growth over the next few years.
In reality, Daily marijuana business reports that legal cannabis sales in the United States are expected to exceed $ 30 billion in 2022. The increase comes after several states adopted recreational and medical cannabis initiatives in 2021, increasing access to marijuana. Insider Reports that 18 states and Washington, DC have now legalized recreational cannabis; and 37 states allow the use of medicinal cannabis.
Below, we’ll give you the scoop on cannabis industry trends and expectations for 2022.
Normalize the grass
A Gallup poll released this year found that 68% of Americans support the legalization of marijuana.
As popular opinion favors cannabis, there is likely to be an even greater incentive for companies to invest in the industry. The popularity of adopting herbal medicine for pain relief will likely increase as well. And, over time, smoking a joint or eating a food can be as socially acceptable as having a glass of wine or opening a beer.
Cannabis research in full swing
We often think of cannabis legalization from a customer perspective, but there is another benefit to its increasing availability.
After a period of sleep, the United States Drug Enforcement Administration decided to allow federally licensed marijuana manufacturers for research. According to an article by Moment Marijuana, this opens the door to studying the characteristics of cannabinoids and how they enter the bloodstream.
Before 1999, there were less than 5,000 published studies on cannabis in total, but with the cannabis reform, over 3,500 peer-reviewed scientific articles were released in 2020 only. This essential work helps de-stigmatize cannabis and reinforces the potential medical benefits of cannabis. Plus, understanding cannabinoids can lead to more effective products.
Clarity in industry
Some consider the blurred line between indica, sativa, and hybrid strains to be a barrier that hinders the marijuana industry. Cannabis connoisseurs understand the names of current spots well, but they can be intimidating to new customers.
Today the amount of named cross hybrids is almost limitless. New hybrid strains are constantly replacing strains as they disappear. And a lot of these hybrids vary between sativa and indica.
Like Sheet reports, this means that the genetic mapping used to understand the genetic material of seeds is essential as it can lead to better clarity between customers and buyers. Research can help distinguish the cannabis experience by using science rather than relying on the subjective experience of the user.
The cannabinoid library
THC and CBD may be the most popular cannabinoids today, but others will soon be in the spotlight.
In total, there are more than 500 cannabinoids – which all interact differently with each individual. Some minor cannabinoids that are gaining ground are CBN, CBG, and THCV.
Cannabinol (CBN) is gaining increasing interest because of its pain relief, insomnia, and general sedative effects. It is similar to CBD in that it has non-psychoactive effects and appears to be very effective as a sleep aid.
Cannabigerol (CBG) is another non-psychoactive cannabinoid. Its promising results in the treatment very specific physiological systems have aroused the interest of the medical community.
THCV is present in most cannabis plants, and this non-psychoactive compound is important because it can mitigate the high level of THC provided. It ends up producing a clear and euphoric state. A new year means new possibilities, with several more states examining measures to legalize the recreational use of cannabis. The sky is the limit how far the cannabis industry can go.
Cannabis Monthly is brought to you by Ionic.
Based in the Pacific Northwest, Ionic is passionate about making the best cannabis oils and cannabis concentrates in small batches. Our pillars of Quality, Responsibility and Respectability are the guiding principles that have inspired the distinctive finish and organized experiences we create.
DISCLAIMER: This product is intoxicating and may be habit forming. Marijuana can interfere with concentration, coordination and judgment. Do not drive a vehicle or machine while under the influence of this medication. There may be health risks associated with the consumption of this product. For use by adults 21 years of age and older. Keep out of the reach of children.